ELV encounters headwinds such as higher benefit costs, an increased debt level and member attrition in the Medicaid business, which…
…
Here’s what could be next for health insurance issuers.…
Markets are settling down, but traders are still making moves in the final hour of Thursdays session. Market Dominations Julie…
…
These are the stocks posting the largest moves in premarket trading.…
…
ELVs third-quarter earnings are hurt by declining membership in Medicaid and Medicare, partially offset by improved product revenues.…
The sale of KRs specialty pharmacy to Elevance Health enables the company to focus on core strengths while enhancing patient…
…
Elevance Health stock PT trimmed by Jefferies amid Medicaid concerns…
…
Elevance Health earnings beat estimates; RBC says no surpises…
Elevance Health said second quarter profits surpassed $2.3 billion as sales of individual coverage and health services growth offset a…
Elevance Health beat Wall Street estimates for quarterly profit on Wednesday, as the health insurer spent less than expected on…
Elevance Health beats quarterly profit estimates…
Elevance Health Inc.’s shares fell the most in over a year Wednesday after management warned medical costs will likely be…
Elevance Health earnings beat by $0.11, revenue topped estimates…
Elevance Healths (ELV) Q2 results gain on strong product revenue growth in the Carelon business and a reduced overall expense…
…
Elevance Healths (ELV) second-quarter results are likely to be aided by improved product revenues, commercial fee-based membership growth, and lower…
Elevance Healths (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.…
…
Todays Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Elevance Health, Inc. (ELV)…
…
Elevance Health hikes 2024 earnings outlook, shares climb…
U.S. stock indexes are ticking higher after a rough run. The S&P 500 was up 0.6% Thursday and on track…
U.S. stock indexes are ticking higher, putting the S&P 500 on track to potentially avoid its longest losing streak since…
Elevance Health (ELV) has a leftover capacity of around $3.6 billion under its share buyback authorization.…
Elevance Health (ELV) forms an alliance with CD&R to enhance primary care delivery by making collective use of the partners…
Elevance Healths (ELV) brand, Anthem Blue Cross and Blue Shield, collaborates to make the benefits of Piedmonts healthcare network available…
Kroger to sell specialty pharmacy business to Elevance Healths CarelonRx…
The infusion services from Paragon Healthcare are expected to complement Elevance Healths (ELV) suite of pharmacy services.…
Elevance Health completes Paragon Healthcare acquisition…
…
…
…
…
Elevance Health earnings matched, revenue topped estimates…
Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.…
Elevance Healths (ELV) fourth-quarter results are likely to reflect higher premiums and product revenues.…
Elevance Health (ELV) launches a new program with an Affordable Connectivity Program offering free smartphones to eligible members.…
Elevance Health (ELV) agrees to acquire Paragon Healthcare, boosting its capabilities in specialty pharmacy.…
Health insurance giant Elevance Health said it has agreed to acquire Paragon Healthcare, Inc., a provider of infusion services to…
Health Care Service Corp. and Elevance Health Inc. are competing to acquire Cigna Group’s business providing medical coverage to people…
In the latest trading session, Elevance Health (ELV) closed at $488.06, marking a +0.94% move from the previous day.…
Elevance Health (ELV) closed the most recent trading day at $476.96, moving -0.28% from the previous trading session.…
Elevance Health is launching a new digital pharmacy that allows health plan enrollees to engage more with pharmacists and track…
Der Kurs der der Aktie von Elevance Health kommt kaum von der Stelle. Der jüngste Kurs betrug 477,79 US-Dollar. Der…
Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.…